Case Studies in HIV Prevention Among Communities at High Risk for HIV

Educational Need:

Access to HIV prevention, including preexposure prophylaxis (PrEP) continues to improve. Despite this progress, PrEP access remains unevenly distributed among race and gender. Preliminary CDC data show only 9% (42,372) of the nearly 469,000 Black people who could benefit from PrEP received a prescription in 2020. While cis gender women make up almost 25% of people living with HIV in the US and excess risk of cardiovascular and cerebrovascular events in individuals with HIV are amplified in women, PrEP coverage was also about three times less in 2020 among cis gender women (10%) as compared to males (28%). In order reduce new HIV infections in the U.S. by 90% by 2030, scaling up HIV prevention and treatment strategies in these populations will be critically important.

Using a combination of didactic presentation and case vignettes, this free interactive CME/CNE/CPE-certified webinar will aim to discuss and propose how multidisciplinary teams can implement solutions to overcome HIV prevention barriers faced by these populations.

Learning Objectives:

After participating in the activity, learners should be better able to:

Identify potential missed opportunities to introduce HIV prevention among Black individuals and among cis gender women
List the key components of effective sexual health history taking technique
Create a workflow with your care team to engage patients in HIV prevention efforts and retain them in care

Activity Co-Faculty

Faculty Bios

Minh Q. Ho, MD, is an infectious disease physician with experience in adult medicine, infectious disease and public health. He has been with Orlando VA Healthcare System (OVAHCS) since 2016 as a clinical hospital epidemiologist. He also works closely with medical students and residents in his role as a faculty with University of Central Florida Department of Medicine. Dr. Ho also plays an active role as site investigator for several funded research from VA Office of Research and Development and National Heart, Lung, and Blood Institute (NHLBI). In his clinical role, he practices general infectious disease with emphasis on HIV, Preexposure Prophylaxis and persons who inject drugs. He helped to create and currently leads RIS4E, a harm reduction program with emphasis on providing sterile syringes, STI/HIV testing, naloxone as well as connecting veterans to other VA services such as mental health.

Karen Slazinski, PharmD, BCPS, AAHIVP, has been an outpatient ID pharmacist at the Orlando VA Medical Center for the past 20 years. She received her PharmD degree from the University of Florida, then completed a Pharmacy Residency at the Gainesville, Florida VA. There she continued as the inpatient infectious disease pharmacist for 6 years. She was ACCP board certified in Pharmacotherapy in 1995 and ASCP board certified in Geriatrics in 1997 and has been credentialed by the American Academy of HIV Medicine since 2008. At the Orlando VA Medical Center, she focuses on PrEP, HIV and hepatitis. For the past 2 years she has acted as the HHRC National PrEP QI Pharmacy Lead.

Target Audience:

This activity has been designed to meet the educational needs of the HIV care team, including physicians (both specialists and primary care/family medicine), NPs, PAs, nurses, and pharmacists who are in training or who are in practice but are new to HIV medicine. Other healthcare providers may also participate.

Accreditation and Credit Designation

Physicians

American Academy of CME, Inc., designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours

California

Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.0 contact hours.

Physician Assistants:

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Pharmacists:

This activity provides 1.0 ACPE contact hours (0.1 CEUs) of continuing education credit. Universal Activity Number JA4008191-0000-22-057-L02-P Application.

Instructions on How to Receive Credit

There are no fees to participate in the activity. Participants must register and participate in the live activity. To receive CME/CE credit for your participation, please follow the directions at the conclusion of the program and complete the program evaluation.

CE certificates will be distributed via email to non-pharmacists. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only pharmacy learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.

The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2022. This accredited continuing education activity is held as copyrighted © by American Academy of CME. Through this notice, permission is granted for its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).